Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Monday, May 18, 2015

PARADIGMS - A Research Study for Children with Multiple Sclerosis (MS)


PARADIGMS is a 24-month research study intended to see if an FDA-approved oral disease modifying treatment (DMT) for adult patients can help children with MS.

If your child has been diagnosed with MS and is 10 to 17 years old, they may be eligible to participate. There is no cost for participation in this study.

What is the PARADIGMS study?

This study is designed to last for 24 months. Qualified volunteers will be randomly assigned (like flipping a coin) into one of two study groups. One of the study groups will be an oral medication and the other study group will be an injectable medication. Both medications have been approved in many countries for use in adult patients (18 and older) for treating multiple sclerosis.

Why should my child participate?

During the 24-month study period, your child will have access to study medication and study related medical assessments at no cost. This study will also help the MS and medical providers gather valuable information about the effectiveness and tolerability of an oral medication in patients less than 18 years of age.

After participating in the 24-month research study, your child may be eligible to take part in an optional long-term extension study.

Learn more by clicking here   and even more here on Facebook

 Keep CURRENT with MS Views and NewsOPT-IN here


No comments: